These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7889632)
41. Platelet vasopressin receptors in patients with congenital nephrogenic diabetes insipidus. Bichet DG; Arthus MF; Lonergan M Kidney Int; 1991 Apr; 39(4):693-9. PubMed ID: 1828844 [TBL] [Abstract][Full Text] [Related]
42. Treatment with cilazapril, angiotensin-converting enzyme inhibitor, changes the affinity of arginine vasopressin receptor in the kidney of the spontaneously hypertensive rat. Nishida N; Ogura T; Yamauchi T; Hosoya M; Ota Z Res Commun Chem Pathol Pharmacol; 1994 May; 84(2):143-52. PubMed ID: 8091000 [TBL] [Abstract][Full Text] [Related]
43. Through V2, not V1 receptor relating to endogenous opiate peptides, arginine vasopressin in periaqueductal gray regulates antinociception in the rat. Yang J; Chen JM; Liu WY; Song CY; Lin BC Regul Pept; 2006 Dec; 137(3):156-61. PubMed ID: 17011056 [TBL] [Abstract][Full Text] [Related]
44. Mechanism of arginine vasopressin suppression of ovine fetal lung fluid secretion: lack of V2-receptor effect. Albuquerque CA; Nijland MJ; Ross MG J Matern Fetal Med; 1998; 7(4):177-82. PubMed ID: 9730483 [TBL] [Abstract][Full Text] [Related]
45. Vasopressin induces dopamine release and cyclic AMP efflux from the brain of water-deprived rats: inhibitory effect of vasopressin V2 receptor-mediated phosphorylation. Tyagi MG; Handa RK; Stephen PM; Bapna JS Biol Signals Recept; 1998; 7(6):328-36. PubMed ID: 9873154 [TBL] [Abstract][Full Text] [Related]
46. Hyper-methylation of AVPR1A and PKCĪ gene associated with insensitivity to arginine vasopressin in human pre-eclamptic placental vasculature. Gao Q; Li H; Ding H; Fan X; Xu T; Tang J; Liu Y; Chen X; Zhou X; Tao J; Xu Z EBioMedicine; 2019 Jun; 44():574-581. PubMed ID: 31175056 [TBL] [Abstract][Full Text] [Related]
47. Iodination of vasopressin analogues with agonistic and antagonistic properties: effects on biological properties and affinity for vascular and renal vasopressin receptors. Jard S; Lombard C; Seyer R; Aumelas A; Manning M; Sawyer WH Mol Pharmacol; 1987 Sep; 32(3):369-75. PubMed ID: 2959851 [TBL] [Abstract][Full Text] [Related]
48. A Pregnant Woman with Excess Vasopressinase-Induced Diabetes Insipidus Complicated by Central Diabetes Insipidus like Lymphocytic Infundibulo-Neurohypophysitis. Yanagisawa S; Oikawa Y; Endo M; Inoue K; Nakajima R; Yasuda S; Sato M; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Isshiki M; Shimada A Case Rep Endocrinol; 2024; 2024():8687054. PubMed ID: 38646198 [TBL] [Abstract][Full Text] [Related]
49. Arginine vasopressin increases renal sodium excretion in the anesthetized rat through V1 receptors. Musabayane CT; Forsling ML; Balment RJ Ren Fail; 1997 Jan; 19(1):23-32. PubMed ID: 9044449 [TBL] [Abstract][Full Text] [Related]
50. Control of renal medullary blood flow by vasopressin V1 and V2 receptors. Nakanishi K; Mattson DL; Gross V; Roman RJ; Cowley AW Am J Physiol; 1995 Jul; 269(1 Pt 2):R193-200. PubMed ID: 7631893 [TBL] [Abstract][Full Text] [Related]
51. Arginine vasopressin as an intragonadal hormone in Brattleboro rats: presence of a testicular vasopressin-like peptide and functional vasopressin receptors. Kasson BG; Hsueh AJ Endocrinology; 1986 Jan; 118(1):23-31. PubMed ID: 3000735 [TBL] [Abstract][Full Text] [Related]
52. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin. Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985 [TBL] [Abstract][Full Text] [Related]
53. Effect of vasopressin V1- and V2-receptor stimulation on blood pressure in DOCA-salt hypertensive rats. Mimura Y; Ogura T; Yamauchi T; Otsuka F; Oishi T; Harada K; Hashimoto M; Ota Z Acta Med Okayama; 1995 Aug; 49(4):187-94. PubMed ID: 7502678 [TBL] [Abstract][Full Text] [Related]
54. Characterization of human platelet vasopressin receptor and the relation between vasopressin-induced platelet aggregation and vasopressin binding to platelets. Inaba K; Umeda Y; Yamane Y; Urakami M; Inada M Clin Endocrinol (Oxf); 1988 Oct; 29(4):377-86. PubMed ID: 2978018 [TBL] [Abstract][Full Text] [Related]
55. In vivo diuretic actions of renal vasopressin V1 receptor stimulation in rats. Ledderhos C; Mattson DL; Skelton MM; Cowley AW Am J Physiol; 1995 Mar; 268(3 Pt 2):R796-807. PubMed ID: 7900923 [TBL] [Abstract][Full Text] [Related]
56. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor. Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327 [TBL] [Abstract][Full Text] [Related]
57. Vasopressin V1 receptor in rat hippocampus is regulated by adrenocortical functions. Saito R; Ishiharada N; Ban Y; Honda K; Takano Y; Kamiya H Brain Res; 1994 May; 646(1):170-4. PubMed ID: 8055336 [TBL] [Abstract][Full Text] [Related]
58. Epidermal growth factor antagonizes vasopressin in vivo and in vitro. Phillips PA; Grant SL; Davidson AF; Risvanis J; Stephenson J; Gow CB Kidney Int; 1994 Apr; 45(4):1028-36. PubMed ID: 8007572 [TBL] [Abstract][Full Text] [Related]
59. Lateral mobility of the antagonist-occupied V2 vasopressin receptor in membranes of renal epithelial cells. Pavo I; Jans DA; Peters R; Penke B; Fahrenholz F Biochim Biophys Acta; 1994 Sep; 1223(2):240-6. PubMed ID: 8086494 [TBL] [Abstract][Full Text] [Related]
60. Identification and characterization of vascular (V1) vasopressin receptors of an established smooth muscle cell line. Stassen FL; Heckman G; Schmidt D; Aiyar N; Nambi P; Crooke ST Mol Pharmacol; 1987 Mar; 31(3):259-66. PubMed ID: 2951584 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]